PlainRecalls
FDA Drug Low Class III Terminated

Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 47335-0063-86

Reported: March 29, 2023 Initiated: March 9, 2023 #D-0474-2023

Product Description

Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 47335-0063-86

Reason for Recall

Failed Content Uniformity Specifications

Details

Units Affected
1,920 bottles
Distribution
USA nationwide.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Dofetilide Capsules, 500 mcg (0.5 mg), 60-count bottle, Rx only, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 47335-0063-86. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 1,920 bottles.
Why was this product recalled?
Failed Content Uniformity Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on March 29, 2023. Severity: Low. Recall number: D-0474-2023.